233 related articles for article (PubMed ID: 32276015)
1. One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass.
Krievins DK; Halena G; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Nair K; Holden A; Schmidt A
J Vasc Surg; 2020 Nov; 72(5):1648-1658.e2. PubMed ID: 32276015
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System.
Halena G; Krievins DK; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Schmidt A; Zdunek M; Lyden SP
J Endovasc Ther; 2022 Feb; 29(1):84-95. PubMed ID: 34465223
[TBL] [Abstract][Full Text] [Related]
3. DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.
Lyden SP; Soukas PA; De A; Tedder B; Bowman J; Mustapha JA; Armstrong EJ;
J Vasc Surg; 2024 Jun; 79(6):1420-1427.e2. PubMed ID: 38367850
[TBL] [Abstract][Full Text] [Related]
4. Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass.
Schneider PA; Krievins DK; Halena G; Schmidt A; Lyden S; Lee V; Hu M; Adelman M
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1266-1272.e3. PubMed ID: 33429092
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
7. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of native superficial femoral artery chronic total occlusion recanalization after failed femoropopliteal bypass.
Davies MG; El-Sayed HF
J Vasc Surg; 2017 Mar; 65(3):726-733. PubMed ID: 28236917
[TBL] [Abstract][Full Text] [Related]
9. The DETOUR procedure: no more need for conventional bypass surgery?
Krievins D; Savlovskis J; Ezite N; Hill A; Kisis K; Gedins M; Zellans E; Holden A
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):172-177. PubMed ID: 29327570
[TBL] [Abstract][Full Text] [Related]
10. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
[TBL] [Abstract][Full Text] [Related]
11. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices.
Mendes BC; Oderich GS; Fleming MD; Misra S; Duncan AA; Kalra M; Cha S; Gloviczki P
J Vasc Surg; 2014 Feb; 59(2):359-367.e1. PubMed ID: 24461861
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
15. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
[No Abstract] [Full Text] [Related]
17. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
[TBL] [Abstract][Full Text] [Related]
18. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
[TBL] [Abstract][Full Text] [Related]
19. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
20. Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial.
Böhme T; Noory E; Brechtel K; Scheinert D; Bosiers M; Beschorner U; Zeller T
J Endovasc Ther; 2021 Apr; 28(2):222-228. PubMed ID: 33044119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
